FDA Clears Simplexa Group A Strep Direct Test
CE marked and assigned to moderate complexity status in the United States, the Simplexa PCR-based strep A direct test by Focus Diagnostics is now available internationally.
Read MorePosted by Steve Halasey | Apr 27, 2015 | Infectious Diseases, Molecular Diagnostics |
CE marked and assigned to moderate complexity status in the United States, the Simplexa PCR-based strep A direct test by Focus Diagnostics is now available internationally.
Read MorePosted by Steve Halasey | Apr 14, 2015 | Research |
Using NanoString’s nCounter analysis system as a platform, the partners aim to jointly discover and validate biomarker signatures for immuno-oncology and targeted therapeutics.
Read MorePosted by Elaine Sanchez Wilson | Apr 7, 2015 | Computing Systems, Information Technology |
In clinical labs, the application of modern lab informatics systems covers a growing range of uses.
Read MorePosted by Elaine Sanchez Wilson | Apr 2, 2015 | Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Urinalysis & Toxicology |
Featured chemistry and integrated analyzers include the Arkray Aution Hybrid AU-4050 analyzer system from US Arkray Inc, the Advia Chemistry XPT system from Siemens Healthcare, and the Cobas 8000 analyzer series from Roche Diagnostics.
Read MorePosted by Elaine Sanchez Wilson | Mar 27, 2015 | Emerging & Zoonotic Diseases, Infectious Diseases |
Delivering results in less than 2 hours, the Xpert ebola test has been authorized for use by CLIA moderate- and high-complexity laboratories or similarly qualified non-US laboratories.
Read More